Celebrating Our Chief Scientific Officer, Dr. Richard Wooster, 25 Years After the Discovery of the BRCA2 Gene

December 21, 2020

25 years ago, our Chief Scientific Officer, Dr. Richard Wooster, was part of a historic scientific discovery.

In December 1995, a team of researchers at The Institute of Cancer Research (ICR), London, published a paper identifying the second breast cancer susceptibility gene, better known as BRCA2. Translate Bio’s Chief Scientific Officer, Dr. Richard Wooster, was part of this incredible group of researchers at the ICR.

There are more than 40 co-authors on the paper published in Nature from institutes and universities around the world. This discovery transformed the field of cancer research and had an impact on millions of people’s lives.

Today, we join the scientific community in recognizing Richard’s significant contribution to science and medicine.

In this spotlight, Richard Wooster, Translate Bio’s Chief Scientific Officer, discusses the 25th anniversary of the discovery of the BRCA2 gene, learnings from this momentous scientific achievement and how it applies to his work at Translate Bio developing a new class of mRNA medicines.

To learn more, read the blog post from ICR celebrating this historic anniversary.

Congratulations, Richard, from the entire team at Translate Bio!